Related references
Note: Only part of the references are listed.Extracellular vesicle-mediated transfer of constitutively active MyD88L265P engages MyD88wt and activates signaling
Mateja Mancek-Keber et al.
BLOOD (2018)
Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
A. Betsch et al.
BLOOD REVIEWS (2018)
Role of extracellular vesicles in rheumatoid arthritis
Haitao Fu et al.
MOLECULAR IMMUNOLOGY (2018)
Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma
Elliot T. Byford et al.
PLOS ONE (2018)
Acquired natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
Jodi Chiu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes
Biyu Xu et al.
TUMOR BIOLOGY (2017)
mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish lymphoma oncology group
Mariano Provencio et al.
ONCOTARGET (2017)
Mesenchymal stromal cells promote B-cell lymphoma in lacrimal glands by inducing immunosuppressive microenvironment
Min Joung Lee et al.
ONCOTARGET (2017)
T follicular helper cells: a potential therapeutic target in follicular lymphoma
Jordi Ochando et al.
ONCOTARGET (2017)
Role of Natural Killer Cells in HIV-Associated Malignancies
Fabio E. Leal et al.
FRONTIERS IN IMMUNOLOGY (2017)
The role of novel immunotherapies in non-Hodgkin lymphoma
Allyson Pishko et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Role of the microenvironment across histological subtypes of NHL
Karin Tarte
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
Baoping Guo et al.
BMC MEDICINE (2016)
Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma
Eri Matsuki et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
Santosha Vardhana et al.
HAEMATOLOGICA (2016)
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
Santosha Vardhana et al.
HAEMATOLOGICA (2016)
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
Jerome Paggetti et al.
BLOOD (2015)
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Achim Rothe et al.
BLOOD (2015)
Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator
Han Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Lymphoma immunotherapy: current status
Roberta Zappasodi et al.
FRONTIERS IN IMMUNOLOGY (2015)
Several immune escape patterns in non-Hodgkin's lymphomas
Camille Laurent et al.
ONCOIMMUNOLOGY (2015)
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
Alessandra Romano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Long-Term Follow-Up of R-CHOP With Bevacizumab as Initial Therapy for Mantle Cell Lymphoma: Clinical and Correlative Results
Jia Ruan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Birgitta Sander et al.
HAEMATOLOGICA (2014)
The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component
Yuxuan Liu et al.
SEMINARS IN CANCER BIOLOGY (2014)
The tumour microenvironment in B cell lymphomas
David W. Scott et al.
NATURE REVIEWS CANCER (2014)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
Jia Ruan et al.
BLOOD (2013)
Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure
Jing He et al.
IMMUNITY (2013)
Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment
Seema Rawal et al.
JOURNAL OF IMMUNOLOGY (2013)
Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies
Nicolas Guillaume et al.
LEUKEMIA RESEARCH (2013)
Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
Katrin S. Reiners et al.
MOLECULAR THERAPY (2013)
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
Peter T. Sage et al.
NATURE IMMUNOLOGY (2013)
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Jianhua Li et al.
NATURE IMMUNOLOGY (2013)
Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models
Zhimin Li et al.
PLOS ONE (2013)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
Fabien Guilloton et al.
BLOOD (2012)
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
Guangwen Ren et al.
CELL STEM CELL (2012)
Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
Claudia Nunes et al.
CLINICAL CANCER RESEARCH (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
Zhi-Zhang Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Yi Lin et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Antiangiogenic Therapies in Non-Hodgkin's Lymphoma
J. Ruan
CURRENT CANCER DRUG TARGETS (2011)
Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results
Joshua Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Four types of Tregs in malignant lymphomas
Jing Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Analysis of CCL5 expression in classical Hodgkin's lymphoma L428 cell line
Fanrong Liu et al.
MOLECULAR MEDICINE REPORTS (2011)
The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma
Ljubomir R. Jakovic et al.
LEUKEMIA & LYMPHOMA (2011)
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
Tint Lwin et al.
BLOOD (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The Evolution of Extracellular Matrix
Suat Oezbek et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox et al.
BLOOD (2009)
Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-kB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-Mediated Cytotoxicity
Boris Boell et al.
CLINICAL CANCER RESEARCH (2009)
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
Daphne de Jong et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma
Joaquim Carreras et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development of a Fully Human Anti-PDGFR beta Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody
Juqun Shen et al.
NEOPLASIA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV
Veronique Minard-Colin et al.
BLOOD (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells - how diverse signals regulate suppression
Bin Li et al.
IMMUNOLOGY (2008)
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
Donatella Aldinucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial
Danielle Canioni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
Kristian Pietras et al.
PLOS MEDICINE (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
RNA fingerprints provide direct evidence for the inhibitory role of TGFβ and PD-1 on CD4+ T cells in Hodgkin lymphoma
Jens M. Chemnitz et al.
BLOOD (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD8+T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma
Bjoern Engelbrekt Wahlin et al.
CLINICAL CANCER RESEARCH (2007)
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Paolo P. Provenzano et al.
BMC MEDICINE (2006)
Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma
Yasuhiko Kitadai et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients
Tomas Alvaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Inhibitory effects of B cells on antitumor immunity
Satoshi Inoue et al.
CANCER RESEARCH (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Chemokines, chemokine receptors, and cancer metastasis
Takashi Kakinuma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of Ick.: Implications in Hodgkin's lymphoma
JM Chemnitz et al.
CANCER RESEARCH (2006)
Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications
P Korkolopoulou et al.
LEUKEMIA (2005)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dendritic cells and their potential therapeutic role in haematological malignancy
ER Kaminski et al.
LEUKEMIA & LYMPHOMA (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Suppression of lymphoma and epithelial malignancies effected by interferon γ
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
C Buri et al.
BLOOD (2001)
Fas ligand expression in Hodgkin lymphoma
CS Verbeke et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
